Shalby Limited (Shalby Hospitals), the multi-specialty hospitals chain, headquartered at Ahmedabad has entered into an agreement (MOU) with Gleneagles Global Health City, Chennai for Heart & Lung Transplant Program, on March 23, 2018. Gleneagles is accredited by several international agencies and has pioneered several advanced procedures in heart, lung, neuro and kidney diseases.
Shalby Hospitals has a Comprehensive Cardiac Sciences Department which offers services in the areas of Adult and Pediatric Cardiology, encompassing Cardiovascular & Thoracic Surgery, Interventional Cardiology, Cardiac Surgery and treatment for congenital heart diseases.
“The Heart & Lung transplant program with Gleneagles Global Health City will further augment Shalby’s super specialty treatment lines. Under the aegis of this MOU, both the companies will endeavour to establish state-of-the art, Heart & Lung Transplant Centres, across all Shalby Units in India. Gleneagles will provide comprehensive medical care facilities to patients at Shalby with regard to Heart & Lung transplants. Training and knowledge sharing between the consultants of both organizations is another area, the MOU envisages. This arrangement will facilitate patients and families residing in tier- II & tier-III cities and its catchment areas in a big way, by reducing their dependence on select metro cities for such life saving programs” said Dr. Vikram I. Shah, CMD, Shalby Limited.
“Gleneagles Global has performed 65 transplants in the past 12 months at its centres in Chennai and Hyderabad. This is the country’s premier solid organ thoracic transplant program (Heart and Lungs) with results that are close to benchmark of outcomes and quality of care. We are confident that we will bring the same care and expertise to our association at Shalby Hospitals in Western and Central India.” said Dr. Sandeep Attawar. The Program Director and Chair (Cardiac Sciences), Thoracic Organ Transplant, Mechanical Circulatory Support, Academic Program.
